Immediate Impact
1 by Nobel laureates 3 from Science/Nature 72 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
A Basic Review on Estrogen Receptor Signaling Pathways in Breast Cancer
2023 Standout
Works of Meredith Buxton being referenced
Adaptively randomized trial of neoadjuvant chemotherapy with or without the Akt inhibitor MK-2206: Graduation results from the I-SPY 2 Trial.
2015
Abstract S5-02: Veliparib/carboplatin plus standard neoadjuvant therapy for high-risk breast cancer: First efficacy results from the I-SPY 2 TRIAL
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Meredith Buxton | 83 | 62 | 36 | 54 | 13 | 172 | |
| Silvia Mezzalira | 72 | 39 | 20 | 21 | 8 | 201 | |
| Muriel Duluc | 147 | 40 | 34 | 30 | 11 | 224 | |
| Chensheng W. Zhou | 171 | 42 | 91 | 93 | 11 | 257 | |
| Zhongying Cao | 36 | 58 | 13 | 60 | 13 | 263 | |
| Samantha Armstrong | 138 | 59 | 58 | 40 | 19 | 265 | |
| Qian Shi | 112 | 32 | 22 | 35 | 14 | 299 | |
| Anna Julienne Selbé Ndiaye | 39 | 24 | 39 | 62 | 14 | 273 | |
| Yin Huei Pang | 40 | 20 | 30 | 80 | 14 | 221 | |
| Alex R. Menter | 76 | 22 | 21 | 43 | 9 | 146 | |
| Jérémie Rouger | 65 | 23 | 14 | 25 | 16 | 180 |
All Works
Login with ORCID to disown or claim papers
Loading papers...